← All stocks

RHYTHM PHARMACEUTICALS, INC.

RYTM Scheduled selling only

CIK 0001649904 #1081 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$11.75M

$0.00 on a plan · $11.75M straight out of an exercise

Sold at will

$0.00

0 of 8 sales

Net

−$11.75M

$0.00 against sales at will

By person

15 insiders · 8 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Smith Hunter C

Chief Financial Officer

—

$6.62M (3) scheduled

−$6.62M

114,024

0.1656%

$11.99M

+16.4%

Meeker David P

President and CEO

—

$5.13M (5) scheduled

−$5.13M

239,258

0.3475%

$25.17M

+32.3%

Mazabraud Yann

EVP, Head of International

—

55,655

0.0808%

$5.85M

+59.6%

Cramer Pamela J.

Chief Human Resources Officer

—

29,376

0.0427%

$3.09M

+117.6%

Mathers Edward T

Director

—

21,168

0.0307%

$2.23M

+141.3%

Shulman Joseph

Chief Technical Officer

—

15,915

0.0231%

$1.67M

—

Arbuckle Stuart A

Director

—

11,712

0.0170%

$1.23M

+290.4%

MCGIRR DAVID W J

Director

—

11,712

0.0170%

$1.23M

+290.4%

JEAN CHRISTOPHE

Director

—

11,712

0.0170%

$1.23M

+290.4%

TETRAULT LYNN A.

Director

—

11,712

0.0170%

$1.23M

+290.4%

GOOD JENNIFER L

Director

—

11,712

0.0170%

$1.23M

+290.4%

Bedrosian Camille L

Director

—

7,000

0.0102%

$736.33K

+133.3%

Garfield Alastair

Chief Scientific Officer

—

2,295

0.0033%

$241.41K

—

Lee Jennifer Kayden

EVP, Head of North America

—

0.0000%

$0.00

−100.0%

German Christopher Paul

Corporate Controller & CAO

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Meeker David P

14 Sep 2026

President and CEO

Sold after exercise

2,300

$105.19

$241.94K

Meeker David P

14 Sep 2026

President and CEO

Sold after exercise

1,817

$104.55

$189.96K

Meeker David P

14 Sep 2026

President and CEO

Sold after exercise

8,698

$103.43

$899.63K

Meeker David P

14 Sep 2026

President and CEO

Sold after exercise

30,746

$102.35

$3.15M

Meeker David P

14 Sep 2026

President and CEO

Sold after exercise

6,439

$101.75

$655.15K

Smith Hunter C

31 Aug 2026

Chief Financial Officer

Sold after exercise

28,188

$106.20

$2.99M

Smith Hunter C

31 Aug 2026

Chief Financial Officer

Sold after exercise

11,514

$105.37

$1.21M

Smith Hunter C

31 Aug 2026

Chief Financial Officer

Sold after exercise

23,072

$104.59

$2.41M

Show all 8 transactions →

RHYTHM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out